drugset / Trial / NCT04128137
Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the efficacy of a 4-week fludrocortisone (FLU) treatment on systolic blood pressure depression after 5 minutes of active orthostatism in patients with neurogenic orthostatic hypotension (HON) symptomatic, despite treatment with non-drug measures with or without midodrine.
Timeline
- Start
- 2020-07-09
- Primary completion
- 2024-06
- Completion
- 2024-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fludrocortisone | Other / unclassified | 200 ug | — |